Photo: Rediffmail
WHO Gives Approval To Bharat Bitoech's Covaxin For Emergency Use
World Health Organisation's (WHO), Technical Advisory Group (TAG) reportedly gave Emergency Use Listing (EUL) status to Bharat Biotech's Covaxin on November 3. Covaxin has been found 77.8% effective against symptomatic COVID-19 and 65% against the new Delta Variant. The decision came after the WHO had sought more clarifications from the company on October 26. Covaxin has become the second Indian vaccine to get the status after Covishield. … read-more
Tags: WHO, emergency use, Bharat biotech, Covaxin, approval
Courtesy: The Times of India
Photo: Business Standard
Australia Annonuces To Recongnise Covaxin As COVID-19 Vaccine
In a major boost to Bharat Biotech, Australia on November 1 announced that it's added the company's Covaxin to the list of approved COVID-19 vaccines in the country. The decision was announced by Australia's High Commissioner to India Barry O'Farrell on Twitter. Reportedly, the decision will help many who've received Covaxin and wants to travel to Australia. The country already recognises the Covishield Vaccine of AstraZeneca India.
Tags: Australia, Covaxin, Covid-19, vaccine, Bharat biotech
Courtesy: ANI
Photo: Business Standard
WHO Requests Explanations On Covaxin; To Reconvene On November 3 For Final Review
WHO announced on October 26, that Technical-Advisory-Group (TAG) for Emergency-Use-Listing (EUL) has made the decision that added clarifications from Bharat-Biotech are required before a final EUL risk-benefit assessment for global use of Covaxin can be conducted. WHO stated that TAG “expects to receive these clarifications by the end of this week, and aims to reconvene on November 3”. Covaxin's acceptance by foreign countries is contingent… read-more
Tags: Covaxin, Bharat biotech, WHO, Emergency Use Authorization
Courtesy: The Indian Express
Photo: Business Insider
WHO To Soon Announce Its Review On India's Covaxin
The World Health Organisation is expected to review and take a final call on an emergency use listing for Covaxin shots on October 26. The organisation is reviewing the data to decide whether the approval will be given for which several Indians are waiting to travel abroad. If all goes well, the positive decision of the WHO will help Indians who've received the vaccine.
Tags: covid 19, Covaxin, Bharat biotech, WHO
Courtesy: Reuters
Photo: The Week
WHO Team Likely To Approve Covaxin's Emergency Use In Next Meet
Chief Scientist at the World Health Organisation Soumya Swaminathan on October 17 said that the technical advisory group of the WHO will consider the Emergency use listing for Covaxin during the meeting on October 26. If the approval is granted, it'll expand the list of vaccines approved by the WHO to send it to poor countries. Reportedly, Covaxin's manufacturer Bharat Biotech is also hopeful to get the approval.
Tags: Covaxin, WHO, Emergency Use Listing, Bharat biotech
Courtesy: WION
Photo: Firstpost
Bharat Biotech Awaits Approval To Roll Out Covaxin To Children Aged 2-8 Yrs
Bharat Biotech after submitting vaccine trial reports of "Covaxin" amongst beneficiaries aged between 2-8 years, said that they are awaiting the approval from the drug regulators. Upon receiving approval, Covaxin will become "one of the first vaccines in the world" to be administered to beneficiaries belonging to the said age group. After reviewing the results, the Subject Expert Committee (SEC) recommended the grant of the vaccine.
Tags: Bharat biotech, Covaxin, DCGI, Vaccine Trial
Courtesy: ANI News
Photo: Gavi, The Vaccine Alliance
WHO Approves World's First RTS,S Vaccine Against Parasitic Diseases
WHO authorised the world's first vaccine against any parasitic diseases on October 6, bringing three decades of scientific work to completion. GlaxoSmithKline produced RTS,S (brand name Mosquirix), which substantially decreases the risk of severe illness in malaria-infected children. Since 2019, it has been used as part of a trial study in parts of Africa. India's Bharat Biotech is expected to be the only global vaccine manufacturer by 2029… read-more
Tags: WHO, Malaria Vaccine, India, Bharat biotech
Courtesy: The Print
Photo: The Economic Times
WHO Postpones Covaxin Approval To Oct 5: Covid-19
The approval for Emergency Use Authorisation (EUA) of Covaxin, manufactured by Hyderabad-based Bharat Biotech, is now postponed to October 5, by World Health Organization (WHO). WHO's Strategic Advisory Group on Immunization is scheduled to meet on October 5 to grant Covaxin the EUA. A vaccination safety monitoring strategy will be updated on a global, regional, and national level. EUA will be proposed based on Covaxin's trials.
Tags: Covaxin, Covid-19, Covid Vaccine, WHO, Bharat biotech
Courtesy: NDTV
Photo: The Indian Express
Bharat Biotech To Produce Additional 200 M Covaxin In Gujarat
India will now receive vaccines in the market as Health Minister Mansukh Mandaviya has released the first commercial batch of COVID-19 vaccine "Covaxin" developed by Bharat Biotech in its new plant, based in Gujarat's Ankleshwar on August 29. Reportedly, the Hyderabad-based firm in may announced to open the plant to produce 200 million doses of vaccine. Mandaviya also said that it will strengthen the country's fight against coronavirus.
Tags: Covaxin, Bharat biotech, Covid Vaccine, Health Minister, Gujarat
Courtesy: Zee News
Photo: Bharat Biotech
Covid-19: WHO To Likely Approve Covaxin For Emergency Use
India's indigenous vaccination "Covaxin" developed by Bharat Biotech is all set to receive WHO's approval by the August end for Emergency Use of Listing (EUL). This will help solve the crisis of many Indians who wish to travel to foreign nations. Meanwhile, Health Minister Mr.Mansukh Mandaviya and WHO officials will meet and discuss the Covaxin approval. However, the government claims that it followed the "due diligence for authorization".… read-more
Tags: Covaxin, Bharat biotech, WHO, WHO Approval
Courtesy: The Money Control
